Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
18 pending office actions • 17 clients • 18 examiners • 17 art units • 0 of 18 (0%) have an AI response strategy ready
EVENTIDE LAW LLC handles matters in Biotechnology & Pharmaceuticals and records 363 career applications. Its profile shows 19 pending office actions, indicating an active docket in addition to its application history.
The resolved allowance rate is 88.16%, and the average office actions per allowance is 3.52. The allowance rate reflects favorable results among resolved matters, while the action average indicates that multiple examination interactions are commonly associated with allowance.
Applicants can use this profile to assess the relationship between prosecution outcomes and workload. The figures support preparation for recurring responses and amendments in biotechnology and pharmaceutical matters, while the application history provides context for the reported performance measures.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (6%) |
| §103 only | 4 (22%) |
| §112 only | 2 (11%) |
| Double-patenting only | 2 (11%) |
| Double-patenting + other | 2 (11%) |
| Multi-statute (no §101) | 7 (39%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GINES, GEORGE SAMUEL | 1 | 71.4% | +41.3% |
| DELEO, VICTORIA LYNN | 1 | 41.4% | -44.4% |
| OGLES, MATTHEW ERIC | 1 | 50.0% | +58.4% |
| KIRSCH, ANDREW THOMAS | 1 | 50.6% | +34.6% |
| RADOSAVLJEVIC, ALEKSANDAR | 1 | 80.8% | +6.3% |
| ROBITAILLE, JOHN P | 1 | 62.5% | +22.1% |
| PINDERSKI, JACQUELINE M | 1 | 26.8% | +45.4% |
| ABBAS, ABDULRAHMAN MUSTAFA | 1 | 51.6% | +29.8% |
| SYLVESTER, KEVIN | 1 | 47.5% | +27.4% |
| PAK, HANNAH J | 1 | 78.2% | +21.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18821276 | GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA | RADOSAVLJEVIC, ALEKSANDAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257041 | ELASTOMERIC BIOMATERIALS AND THEIR MANUFACTURE | HEINCER, LIAM J | 16d overdue |
| 18561108 | OIL-IN-WATER EMULSION OF 6-ETHOXY-7-METHOXY-2-(2-METHYLSULFANYLPHENYL)-3,L-BENZOXAZIN-4-ONE | BAUER, BRIANNA LEE | 76d |
| 19481759 | FOAM MATTRESS COMPRISING AN UPPER BODY SLIDINGLY ARRANGED OVER A LOWER BODY AND FURTHER ARRANGED WITH INSERTS | GINES, GEORGE SAMUEL | — |
| 18851212 | METHOD OF PREVENTING OVERTRAINING, OR DETERMINING THE APPROPRIATE AMOUNT OF EXERCISE | OGLES, MATTHEW ERIC | — |
| 18892932 | Container for Storing, Transporting and Dispensing a Beverage | KIRSCH, ANDREW THOMAS | — |
| 18841585 | METHOD FOR PREPARING CLOSURE END OF OCCLUDER, AND DEVICE FOR PREPARING CLOSURE END OF OCCLUDER | ROBITAILLE, JOHN P | — |
| 18809819 | NASAL TUBE DEVICES FOR SECURING A NASAL TUBE AND ONE OR MORE OTHER TUBES TO A NOSE OF A PATIENT | PINDERSKI, JACQUELINE M | — |
| 18554513 | PURIFICATION OF PROTEINS | NOAKES, SUZANNE MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18709382 | OIL-BASED SOLID COMPOSITION FOR EXTERNAL USE | ABBAS, ABDULRAHMAN MUSTAFA | 39d |
| 19481759 | FOAM MATTRESS COMPRISING AN UPPER BODY SLIDINGLY ARRANGED OVER A LOWER BODY AND FURTHER ARRANGED WITH INSERTS | GINES, GEORGE SAMUEL | — |
| 18851212 | METHOD OF PREVENTING OVERTRAINING, OR DETERMINING THE APPROPRIATE AMOUNT OF EXERCISE | OGLES, MATTHEW ERIC | — |
| 18892932 | Container for Storing, Transporting and Dispensing a Beverage | KIRSCH, ANDREW THOMAS | — |
| 18841585 | METHOD FOR PREPARING CLOSURE END OF OCCLUDER, AND DEVICE FOR PREPARING CLOSURE END OF OCCLUDER | ROBITAILLE, JOHN P | — |
| 18809819 | NASAL TUBE DEVICES FOR SECURING A NASAL TUBE AND ONE OR MORE OTHER TUBES TO A NOSE OF A PATIENT | PINDERSKI, JACQUELINE M | — |
| 18569962 | ELECTRODE FOR INDUSTRIAL ELECTROLYSIS PROCESS | SYLVESTER, KEVIN | — |
| 18535684 | COPOLYMER, METHOD OF PREPARING THE SAME, RESIN COMPOSITION, AND PRODUCT OF THE SAME | PAK, HANNAH J | — |
| Art Unit | Apps |
|---|---|
| 1662 | 2 |
| 3673 | 1 |
| 3796 | 1 |
| 3733 | 1 |
| 1743 | 1 |
| 3785 | 1 |
| 1612 | 1 |
| 1794 | 1 |
| 1764 | 1 |
| 1618 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19481759 | FOAM MATTRESS COMPRISING AN UPPER BODY SLIDINGLY ARRANGED OVER A LOWER BODY AND FURTHER ARRANGED WITH INSERTS | Care Of Sweden AB | GINES, GEORGE SAMUEL | 3673 | §102§103 | Non-Final OA | — | Pending | Nov 05, 2025 |
| 18881220 | Plants with Modified Deoxyhypusine Synthase Genes | Agribody Technologies, LLC | DELEO, VICTORIA LYNN | 1662 | §112 | Non-Final OA | — | Pending | Jan 03, 2025 |
| 18851212 | METHOD OF PREVENTING OVERTRAINING, OR DETERMINING THE APPROPRIATE AMOUNT OF EXERCISE | Svexa Inc. | OGLES, MATTHEW ERIC | 3796 | §101§103§112 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18892932 | Container for Storing, Transporting and Dispensing a Beverage | The Square Keg LLC | KIRSCH, ANDREW THOMAS | 3733 | §102§103 | Final Rejection | — | Pending | Sep 23, 2024 |
| 18821276 | GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA | Nuseed Nutritional US Inc. | RADOSAVLJEVIC, ALEKSANDAR | 1662 | DP | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18841585 | METHOD FOR PREPARING CLOSURE END OF OCCLUDER, AND DEVICE FOR PREPARING CLOSURE END OF OCCLUDER | Shanghai Shape Memory Alloy Co., Ltd. | ROBITAILLE, JOHN P | 1743 | §102§103 | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18809819 | NASAL TUBE DEVICES FOR SECURING A NASAL TUBE AND ONE OR MORE OTHER TUBES TO A NOSE OF A PATIENT | Applied Medical Technology, Inc. | PINDERSKI, JACQUELINE M | 3785 | §103§112 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18709382 | OIL-BASED SOLID COMPOSITION FOR EXTERNAL USE | Rohto Pharmaceutical Co., Ltd. | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103 | Final Rejection | 39d | Pending | May 10, 2024 |
| 18569962 | ELECTRODE FOR INDUSTRIAL ELECTROLYSIS PROCESS | De Nora Permelec Ltd. | SYLVESTER, KEVIN | 1794 | §103 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18535684 | COPOLYMER, METHOD OF PREPARING THE SAME, RESIN COMPOSITION, AND PRODUCT OF THE SAME | Elite Electronic Material (Zhongshan) Co., Ltd. | PAK, HANNAH J | 1764 | DP | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18563110 | BORONO-PHENYLALANINE DERIVATIVE | Stella Pharma Corporation | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18561108 | OIL-IN-WATER EMULSION OF 6-ETHOXY-7-METHOXY-2-(2-METHYLSULFANYLPHENYL)-3,L-BENZOXAZIN-4-ONE | Sixera Pharma AB | BAUER, BRIANNA LEE | 1623 | §103§112Other | Non-Final OA | 76d | Pending | Nov 15, 2023 |
| 18554513 | PURIFICATION OF PROTEINS | Dermapharm Aktiengesellschaft | NOAKES, SUZANNE MARIE | 1656 | §103§112 | Non-Final OA | — | Pending | Oct 09, 2023 |
| 18554581 | EXTRACELLULAR VESICLES FROM MESENCHYMAL STROMAL CELLS FOR TREATMENT OF DISEASES | Avulotion AB | LARA, CAROLINE MONSERRAT | 1633 | §103DP | Final Rejection | — | Pending | Oct 09, 2023 |
| 18264486 | HUMAN CD33 ANTIBODY AND USE THEREOF | Hainan Simcere Zaiming Pharmaceutical Co., Ltd. | SCHWECHTER, BRANDON ROSS | 1674 | §112 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18257041 | ELASTOMERIC BIOMATERIALS AND THEIR MANUFACTURE | Reselo AB | HEINCER, LIAM J | 1767 | §102§103 | Final Rejection | 16d overdue | Pending | Jun 12, 2023 |
| 18325749 | Plants with Modified Deoxyhypusine Synthase Genes | Agribody Technologies, LLC | KINGDON, CATHY | 1663 | §103§112DP | Final Rejection | — | Pending | May 30, 2023 |
| 17753498 | IMPLANT FOR ATTACHING A TENDON OR A LIGAMENT TO A HARD TISSUE | Alps Holding LLC | BLASS, PARIS MARIE | 3774 | §103 | Non-Final OA | 223d overdue | Pending | Mar 04, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial88.2% of resolved applications prosecuted by Eventide Law LLC were allowed, across 363 applications in USPTO records.
3.52 office actions per allowed application on average.
18 pending office actions as of October 2026, for 17 clients, before 18 examiners in 17 art units.
